{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:04:12Z","timestamp":1790813052400,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T00:00:00Z","timestamp":1417046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00234-014-1468-2","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T08:55:51Z","timestamp":1417510551000},"page":"321-326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["23Na-MRI of recurrent glioblastoma multiforme after intraoperative radiotherapy: technical note"],"prefix":"10.1007","volume":"57","author":[{"given":"Stefan","family":"Haneder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Konstandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Brehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Buesing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schmiedek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar R.","family":"Schad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan O.","family":"Schoenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"issue":"10","key":"1468_CR1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"issue":"24","key":"1468_CR2","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1200\/JCO.2010.30.0582","volume":"28","author":"JK Park","year":"2010","unstructured":"Park JK et al (2010) Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 28(24):3838\u20133843","journal-title":"J Clin Oncol"},{"issue":"1","key":"1468_CR3","first-page":"94","volume":"3","author":"F Giordano","year":"2014","unstructured":"Giordano F et al (2014) Intraoperative radiotherapy (IORT)\u2014a resurrected option for treating glioblastoma? Transl Cancer Res 3(1):94\u2013105","journal-title":"Transl Cancer Res"},{"issue":"1","key":"1468_CR4","first-page":"4","volume":"15","author":"M Weller","year":"2013","unstructured":"Weller M et al (2013) Standards of care for treatment of recurrent glioblastoma\u2014are we there yet? J Neurooncol 15(1):4\u201327","journal-title":"J Neurooncol"},{"issue":"5","key":"1468_CR5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2008.16.3055","volume":"27","author":"TN Kreisl","year":"2009","unstructured":"Kreisl TN et al (2009) Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27(5):740\u2013745","journal-title":"J Clin Oncol"},{"issue":"5","key":"1468_CR6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","volume":"9","author":"D Brandsma","year":"2008","unstructured":"Brandsma D et al (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9(5):453\u2013461","journal-title":"Lancet Oncol"},{"issue":"7","key":"1468_CR7","first-page":"1048","volume":"53","author":"N Galldiks","year":"2012","unstructured":"Galldiks N et al (2012) Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-l-tyrosine PET in comparison to MRI. J Nucl Med Off Publ Soc Nucl Med 53(7):1048\u20131057","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"1468_CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fonc.2013.00104","volume":"3","author":"I Gotz","year":"2013","unstructured":"Gotz I, Grosu AL (2013) [18F]FET-PET imaging for treatment and response monitoring of radiation therapy in malignant glioma patients\u2014a review. Front Oncol 3:104","journal-title":"Front Oncol"},{"key":"1468_CR9","unstructured":"Haneder S, et al (2013) Sodium (23Na)-imaging as therapy monitoring in oncology\u2014future prospects. MAGNETOM Flash. 2 (ISMRM edition)(52):72\u201377"},{"issue":"2","key":"1468_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/oxfordjournals.bmb.a071964","volume":"40","author":"AA Maudsley","year":"1984","unstructured":"Maudsley AA, Hilal SK (1984) Biological aspects of sodium-23 imaging. Br Med Bull 40(2):165\u2013166","journal-title":"Br Med Bull"},{"issue":"3","key":"1468_CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.nic.2005.08.003","volume":"15","author":"KR Thulborn","year":"2005","unstructured":"Thulborn KR et al (2005) Sodium MR imaging of acute and subacute stroke for assessment of tissue viability. Neuroimaging Clin N Am 15(3):639\u2013653, xi\u2013xii","journal-title":"Neuroimaging Clin N Am"},{"issue":"11","key":"1468_CR12","first-page":"5395","volume":"43","author":"I Nagy","year":"1983","unstructured":"Nagy I et al (1983) Correlation of malignancy with the intracellular Na+:K+ ratio in human thyroid tumors. Cancer Res 43(11):5395\u20135402","journal-title":"Cancer Res"},{"issue":"5","key":"1468_CR13","first-page":"1493","volume":"40","author":"IL Cameron","year":"1980","unstructured":"Cameron IL et al (1980) Intracellular concentration of sodium and other elements as related to mitogenesis and oncogenesis in vivo. Cancer Res 40(5):1493\u20131500","journal-title":"Cancer Res"},{"issue":"2","key":"1468_CR14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1148\/radiol.2272020483","volume":"227","author":"R Ouwerkerk","year":"2003","unstructured":"Ouwerkerk R et al (2003) Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology 227(2):529\u2013537","journal-title":"Radiology"},{"issue":"4","key":"1468_CR15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.nic.2009.09.001","volume":"19","author":"KR Thulborn","year":"2009","unstructured":"Thulborn KR et al (2009) Quantitative sodium MR imaging and sodium bioscales for the management of brain tumors. Neuroimaging Clin N Am 19(4):615\u2013624","journal-title":"Neuroimaging Clin N Am"},{"issue":"1","key":"1468_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.zemedi.2013.07.004","volume":"24","author":"M Danisch","year":"2014","unstructured":"Danisch M et al (2014) Bilateral 23Na MR imaging of the breast and quantification of sodium concentration. Z Med Phys 24(1):65\u201372","journal-title":"Z Med Phys"},{"issue":"3","key":"1468_CR17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11060-010-0192-y","volume":"100","author":"F Stockhammer","year":"2010","unstructured":"Stockhammer F et al (2010) Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma. J Neurooncol 100(3):407\u2013415","journal-title":"J Neurooncol"},{"issue":"6","key":"1468_CR18","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/mrm.22157","volume":"62","author":"AM Nagel","year":"2009","unstructured":"Nagel AM et al (2009) Sodium MRI using a density-adapted 3D radial acquisition technique. Magn Reson Med Off J Soc Magn Reson Med Soc Magn Reson Med 62(6):1565\u20131573","journal-title":"Magn Reson Med Off J Soc Magn Reson Med Soc Magn Reson Med"},{"issue":"8956","key":"1468_CR19","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","volume":"345","author":"H Brem","year":"1995","unstructured":"Brem H et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The polymer-brain tumor treatment group. Lancet 345(8956):1008\u20131012","journal-title":"Lancet"},{"issue":"11","key":"1468_CR20","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28(11):1963\u20131972","journal-title":"J Clin Oncol"},{"issue":"6","key":"1468_CR21","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2967\/jnumed.110.086645","volume":"52","author":"M Hutterer","year":"2011","unstructured":"Hutterer M et al (2011) O-(2-18F-fluoroethyl)-l-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma. J Nucl Med 52(6):856\u2013864","journal-title":"J Nucl Med"},{"key":"1468_CR22","doi-asserted-by":"crossref","unstructured":"Ryken TC, et al (2014) The role of imaging in the management of progressive glioblastoma: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-oncology","DOI":"10.1007\/s11060-013-1330-0"},{"issue":"6","key":"1468_CR23","first-page":"2146","volume":"6","author":"RP Kline","year":"2000","unstructured":"Kline RP et al (2000) Rapid in vivo monitoring of chemotherapeutic response using weighted sodium magnetic resonance imaging. Clin Cancer Res Off J Am Assoc Cancer Res 6(6):2146\u20132156","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"7","key":"1468_CR24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1593\/neo.05130","volume":"7","author":"AM Babsky","year":"2005","unstructured":"Babsky AM et al (2005) Application of 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors. Neoplasia 7(7):658\u2013666","journal-title":"Neoplasia"},{"key":"1468_CR25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2867-5-26","volume":"5","author":"R Sharma","year":"2005","unstructured":"Sharma R et al (2005) Rapid in vivo taxotere quantitative chemosensitivity response by 4.23 Tesla sodium MRI and histo-immunostaining features in N-methyl-N-nitrosourea induced breast tumors in rats. Cancer Cell Int 5:26","journal-title":"Cancer Cell Int"},{"issue":"3","key":"1468_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.mri.2005.12.004","volume":"24","author":"VD Schepkin","year":"2006","unstructured":"Schepkin VD et al (2006) Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors. Magn Reson Imaging 24(3):273\u2013278","journal-title":"Magn Reson Imaging"},{"issue":"8","key":"1468_CR27","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/nbm.1074","volume":"19","author":"VD Schepkin","year":"2006","unstructured":"Schepkin VD et al (2006) Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. NMR Biomed 19(8):1035\u20131042","journal-title":"NMR Biomed"},{"issue":"4","key":"1468_CR28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/s-0031-1299277","volume":"184","author":"T Henzler","year":"2012","unstructured":"Henzler T et al (2012) Imaging of tumor viability in lung cancer: initial results using 23Na-MRI. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 184(4):340\u2013344","journal-title":"RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin"},{"issue":"9","key":"1468_CR29","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.mri.2012.05.011","volume":"30","author":"CM Laymon","year":"2012","unstructured":"Laymon CM et al (2012) Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis. Magn Reson Imaging 30(9):1268\u20131278","journal-title":"Magn Reson Imaging"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-014-1468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00234-014-1468-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-014-1468-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T21:57:08Z","timestamp":1566079028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00234-014-1468-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,27]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1007\/s00234-014-1468-2","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,27]]}}}